UNSPSC 51151675: Umeclidinium

A drug administered via oral inhalation for use in adults to control wheezing, shortness of breath, coughing, and chest tightness caused by chronic obstructive pulmonary disease COPD.

UNSPSC 51151675 Umeclidinium, a Commodity code, maps to pharmaceutical products that state and local governments procure for emergency medical and occupational health programs, though recent solicitations show the code capturing a broader pharmacy-services landscape than the specific drug name suggests. State and local issuing bodies soliciting under this code span county health departments and government family health centers seeking to stock emergency medications, operate on-site pharmacy services, or support community health initiatives. The work ranges from purchasing quantities of specific pharmaceuticals like naloxone for quarterly distribution to establishing comprehensive on-site pharmacy operations serving employee and retiree populations with formulary management, dispensing fees, and administrative oversight.

Recent activity appears concentrated in Florida and Georgia. Seminole County, Florida issued IFB 60459723LAS in June 2026 seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries, bidding electronically through the county's e-Procurement Portal and closing July 26, 2023. Hall County, Georgia issued RFQ/P #47-010 in May 2026 for on-site pharmacy services at its Family Health Center Clinic in Gainesville, serving approximately 3,005 eligible individuals across multiple health insurance plans, with a request for qualifications and cost proposal due June 4, 2026, and contract commencement January 1, 2027. Both solicitations require standard state and local compliance documentation including E-Verify affidavits, proof of insurance, and drug-free workplace certifications; Hall County additionally requires cyber insurance ($1,000,000) and emphasizes HIPAA compliance and technology capabilities for pharmacy management systems.